期刊文献+

肌动蛋白聚合蛋白(fascin)和CD44V6在子宫内膜样腺癌组织中的表达及意义 被引量:2

Expression and Significance of Fascin and CD44V6 in Endometrial Adenocarcinoma
下载PDF
导出
摘要 目的:探讨肌动蛋白聚合蛋白(fascin)和CD44V6在子宫内膜样腺癌中的表达情况及其临床意义。方法:应用免疫组化SP法检测46例子宫内膜样腺癌(A组),19例子宫内膜增生症(B组)以及17例正常子宫内膜(C组)组织中fascin和CD44V6的表达情况。结果:①A组中fascin的表达率(71.74%)明显高于B组(15.79%)及C组(5.88%)(P<0.01)。fascin在A组中的表达率与子宫内膜样腺癌的临床分期、组织学分级及淋巴结转移情况相关(P<0.05),而与肌层浸润深度无关(P>0.05)。②A组中CD44V6的表达率(43.48%)明显高于B组(5.26%)及C组(5.88%)(P<0.01)。CD44V6在A组中的表达率与子宫内膜癌的淋巴结转移情况及肌层浸润深度相关(P<0.05),而与临床分期、组织学分级无关(P>0.05)。③fascin与CD44V6在子宫内膜样腺癌组织中的表达呈正相关(r=0.453,P<0.05)。结论:fascin及CD44V6在子宫内膜样腺癌的发生、发展过程中起重要的作用。 Objective: To explore the expression of fascin and CD44V6 in endomerial adenocarcinoma tissues and their clinical significances. Methods: The expressions of fascin, CD44V6 in 46 patients with endometrial adenocarcinoma (group A), 19 patients with endometrial hyperplasia (group B) and 17 patients with normal endometrium (group C) were detected by immunohistoehemistry of streptavidin-peroxidase (SP) method. Results: The expression of fascin protein in group A (71.74%) was higher than that in group B (15.79%) and group C (5.88%). The expression of fascin in group A correlated with their clinical stage, histology grade and lymphatic metastasis. The expression of CD44V6 protein in group A (43.48%) was higher than that in group B (5.26%) and group C (5.88%). The expression of CD44V6 in group A correlated with their lymphatic metastasis and myometrial invasion. The expression of fascin correlated positively with the expression of CD44V6 in group A.Conclusion: Fascin and CD44V6 may play an important role in oncogenesis and development of endometrial adenocarcinoma.
出处 《生殖与避孕》 CAS CSCD 北大核心 2008年第8期471-476,共6页 Reproduction and Contraception
关键词 肌动蛋白聚合蛋白(fascin) CD44V6 子宫内膜样腺癌 fascin CD44V6 endometrial adenocarcinoma
  • 相关文献

参考文献10

  • 1Choi P J, Yang DK, Son CH, et al. Fascin immunoreactivity for preoperatively predicting lymph node metastases in peripheral adenocarcinoma of the lung 3 cm or less in diameter. Eur J Cardiothorac Surg, 2006, 30(3):538-42.
  • 2张殊,林其德,狄文.BRMS1和fascin基因在卵巢上皮癌中的表达及其意义[J].现代妇产科进展,2003,12(3):167-169. 被引量:24
  • 3郑唯强,郑建明,卢建,胡凤仙,倪灿荣.成束蛋白在乳癌的表达及其与雌激素受体的相互关系和意义[J].中国普通外科杂志,2001,10(5):408-411. 被引量:3
  • 4马晓欣,苗青,王晓莉,张淑兰,曲桂红.C-erbB-2蛋白在子宫内膜病变中的表达及临床意义[J].中国现代医学杂志,2006,16(4):550-552. 被引量:2
  • 5陈晓玲,杨戎,贾咏存,魏莎莉.PTEN基因在早孕小鼠子宫内膜的表达规律[J].生殖与避孕,2007,27(2):89-93. 被引量:10
  • 6Hashimoto Y, Shimada Y, Kawamura J, et al. The prognostic relevance of fascin expression in human gastric carcinoma. Oncology, 2004, 67(3-4): 262-70.
  • 7Guan Y, Woo PL, Rubonstein NM, et al. Transforming growth factor-alpha abrogates the glucocorticoid stimulation of tight junction formation and reverses the steroid-induced down-regulation of fascin in rat mammary epithelial tumor cells by a Ras-dependent pathway. Exp Cell Res, 2002, 273(1):1-11.
  • 8蔡斌,万小平.CD44在妇科肿瘤中的研究进展[J].国外医学(妇产科学分册),2003,30(5):313-316. 被引量:2
  • 9Yoshida R, Kimura N, Harada Y, el al. The loss of ecadherin, alpha-and beta-catenin expression is associated with metastasis and poor prognosis in invasive breast cancer, Int J Oncol, 2001, 18(3):513-20.
  • 10Stokes GN, Shelton JB Jr, Zahn CM, et al. Association of CD44 isoform immunohistochemical expression with myometrial and vascular invasion in endometrioid endometrial carcinoma. Gynecol Oncol, 2002, 84(1):58-61.

二级参考文献45

  • 1郑唯强,詹洲,倪灿荣,龚志锦,刘伟强.乳腺癌增殖细胞核抗原同AgNoR和病理学特性的关系[J].实用癌症杂志,1994,9(1):5-7. 被引量:6
  • 2[1]Seraj MJ, Samant RS, Verderame MF, et al. Funcfonal evi dence for a novel human breast carcinoma metastasis suppresor, BRMS1,encoded at chromosome 11q13[J] .Cancer Res, 2000,60:2764-2769
  • 3[2]Weitzel JN, Patel J, Smith DM, et al. Molecular genetic changes associated with ovarian cancer[ J ]. Gynecol Oncol, 1994,55:245-252
  • 4[3]Hu W, Mcrea PD, Deavers M, et al. Increased expression offascin, motility associated protein, in cell cultures derived from ovarian cancer and in borderline and carcinomatous ovarian tu mors[J]. Clin Exp Metastasis,2000,18:83-88
  • 5[4]Josephine CA,James DC, G eorgina DM, et al. Cell-matrix ad hesions differentially regulate fascin phosphorylation [ J ]. Mol Biol Cell, 1999,10:4177-4190
  • 6Skubitz AP. Adhesion molecules. Cancer Treat Res, 2002,107:305-329.
  • 7Ponta H, Sherman L, Herrlich PA. CD44:from adhesion molecules to signalling regulators. Nature Rev Mol Cell Biol, 2003, 4(1):33-45.
  • 8Jeffrey S, Ross MD, Christine E, et al. Decreased CD44 standard form expression correlates with prognostic variables in ovarian carcinomas. Am J Clin Pathol, 2001,116:122-128.
  • 9Bemer HS, Davidson B, Bemer A, et al. Expression of CD44 in effusions of patients diagnosed with serous ovarian carcinoma--diagnostic and prognostic implications. Clin Exp Metastasis, 2000, 18(2): 197-2O2.
  • 10Sancho-Tortes I, Mesonero C, Miller Watelet JL et al. Clear cell carcinoma of the ovary: characterization of its CD44 isoform repertoire.Gynecol Oncol, 2000,79(2): 187-195.

共引文献34

同被引文献34

  • 1王玲,薛慧荣,王艳丽.上皮性钙粘蛋白和β-连环素与子宫内膜癌的关系[J].中国实验诊断学,2006,10(5):478-481. 被引量:8
  • 2罗波,隋媛,丁艳,宋保连,郝建波.CD_(44)v6和上皮钙黏蛋白在膀胱移行细胞癌中的表达及意义[J].中国全科医学,2006,9(20):1675-1677. 被引量:8
  • 3Grove CS, Lee YC. Vascular endothelial grouth factor: the key mediator in pleual effusion formation [ J ]. Curr Opin Pulm Med, 2002,8 (4) : 294-301.
  • 4Zebrowski RK,Liu W,Ramirez K. et al. Markedly elevaled levels of vascular endothelial growth factor in malignant ascites[ J ]. Ann Sury Oneol, 1999,6(4) :373-378.
  • 5Gershenwald JE, Fidler IJ. Cancer: targeting lymphatic metastasis [ J ].Science ,2002,296 ( 5574 ) : 1811-1812.
  • 6Jothy S. CD44 and its partners in metastasis [ J ]. Clinical and Experi- mental Metastasis, 2003,20 (3) : 195-201.
  • 7Hasuml Y, Mizukami H, Urabe M, et al. Soluble FLT-I expression suppresses earcinomatous ascits in nude mice bearing ovarian [ J ], Cancer Research, 2002,62 ( 2 ) : 2019-2023.
  • 8Yabushita H,Shlmazu M, Noguchi M, et al. Vascular endothelial growth factor activating matrix metalloproteinase in ascitic fluid during perito neal dissemination of ovarian cancer[ J ]. Oncol Rep, 2003, 10 ( l ) : 89- 95.
  • 9Yeo KT, Wang HH, Nagy JA, et al. Vascular permeability factor (VEGF) in guinea pig and human tumorand inflammatory effusion[ J]. Cancer Res,2001,53(6) :2912-2918.
  • 10Kraft A,Weindel K, Ochs A,et al. Vascular endothelial growth factor in the sera and effusion of ptients with malignanl and nonmalignant disease [J]. Cancer,1999,85 ( 1 ) :178-187.

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部